Last update 14 Jun 2025

BEBT-607

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BEBT 607, BEBT-607, BEBT607
Target
KRAS G12C
Action
inhibitors
Mechanism
KRAS G12C inhibitors(GTPase KRas G12C inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication
KRAS G12C mutation Solid TumorsKRAS G12C mutant Colorectal CancerKRAS G12C mutant Non-small Cell Lung Cancer+ [1]
Inactive Indication-
Originator Organization
BeBetter Med, Inc.BeBetter Med, Inc.
Active Organization
BeBetter Med, Inc.BeBetter Med, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with BEBT-607
NCT06117371
/ RecruitingPhase 1
A Two-phase, Multicenter, Open Phase I Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation
100 Clinical Results associated with BEBT-607
Login to view more data
100 Translational Medicine associated with BEBT-607
Login to view more data
100 Patents (Medical) associated with BEBT-607
Login to view more data
100 Deals associated with BEBT-607
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
KRAS G12C mutation Solid TumorsPhase 1
China
BeBetter Med, Inc.BeBetter Med, Inc.
04 Sep 2023
KRAS G12C mutant Colorectal CancerPhase 1
China
BeBetter Med, Inc.BeBetter Med, Inc.
-
KRAS G12C mutant Non-small Cell Lung CancerPhase 1
China
BeBetter Med, Inc.BeBetter Med, Inc.
-
KRAS p.G12C mutant pancreatic cancerPhase 1
China
BeBetter Med, Inc.BeBetter Med, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free